Morgan Stanley raised its price objective for Disc Medicine, Inc. on June 30, 2026.
7 reports, 2 independent
Updated Thu 00:00
No new developments lately
- Reports
- 7
- Developments
- 3
- Repetition
- 57%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley raised its price objective for Disc Medicine, Inc. on June 30, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Cantor Fitzgerald added to Morgan Stanley's price target raise for Disc Medicine.1 source
Morgan Stanley boosted its price objective for Disc Medicine, Inc.1 source
Morgan Stanley increased its price target for Disc Medicine.1 source
Keep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank